In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify cannabis for a Routine III drug. This rescheduling will figure out that cannabis has respectable health-related needs and may help open the door to investigate on other possible treatment uses. Go through upcoming Business enterprise Insider tells https://thcdisposables.co.uk/